Rotman School of Management

Main Content

Experts discuss "Entrepreneurial Perspectives on MedTech Strategy"

6:00 to 6:30pm registration check-in; 6:30 to 7:30pm presentations, discussion and Q&A; 7:30 to 8:00pm reception

Event Details


Date: Wednesday February 14, 2018 | 06:30 PM - 08:00 PM
Speaker(s): PANELISTS:
Andrew Ryan, National Marketing Manager, Coronary Group - Canada, Abbott Laboratories
Phil Vasil, Marketing Manager for Electrophysiology (EP) Products, Abbott Canada

HOST: Prof. Will Mitchell, Anthony S. Fell Chair in New Technologies and Commercialization; Professor of Strategic Management, Rotman School of Management, University of Toronto

GUEST HOST: Mark Taylor, Team Lead - Licensing & Commercialization (UHN-TDC), Director of Commercialization, University Health Network (TECHNA)
Topic: "Entrepreneurial Perspectives on MedTech Strategy"
Venue: Classroom 1065 (Main Floor, South Building)| map
Rotman School of Management, U of Toronto,
105 St George Street
Toronto, ON
Location: Toronto
Cost: $25 plus HST per person - register to attend all 4 sessions for $75 plus HST
Register Now

SYNOPSIS: Presented by the Rotman Centre for Health Sector Strategy in partnership with the University Health Network Office of Technology Development & Commercialization, the goal of this series is to address the key strategic trends to aid those working within the industry as well as entrepreneurs or new entrants to the medical devices arena. Topics and examples will focus on Canadian and global companies. Participation will involve focused pre-readings, together with active engagement in discussions during the sessions.

ROTMAN LINK AND LEARN SERIES CERTIFICATE - MEDTECH MODULE: For those who register to attend all four MedTech Sessions you may be eligible for a certificate of completion.

  1. January 24, 2018 - MedTech Session 1: Overview of the MedTech Sector
  2. February 14, 2018 - MedTech Session 2: Entrepreneurial Perspectives on MedTech Strategy
  3. February 28, 2018 - MedTech Session 3: Entrepreneurial Perspectives on MedTech Strategy
  4. March 14, 2018 - MedTech Session 4: Entrepreneurial Perspectives on MedTech Strategy

For more information on Link and Learn Series Certificates and Modules visit the Centre for Health Sector Strategy Website.


Andrew Ryan, National Marketing Manager, Coronary Group-Canada, Abbott Laboratories
He is currently responsible for growth of the Core Coronary portfolio for interventional cardiology devices. In this role, he has helped the team through: Health Care Practitioner (HCP) education, forecasting, GTM strategy, Key Opinion Leader engagement, strategic planning – and much more. Perhaps most importantly, he has been a part of a successful commercial turn around since joining. In this role, ‘typical’ is not a day that exists. The range of responsibilities and skills required for the role are just as varied. Working at Abbott has lent him the opportunity to visit 6 countries in Asia, South America, Central America and every major city in Canada. Having been in a business unit that was acquired at a previous employer, and going through on the buying side of the St. Jude Medical acquisition, he brings a view from both sides of a corporate transaction. He joined the Medical Device industry mid-career after a decade in Business-to-Business (B2B) marketing.

Phil Vasil, Marketing Manager for Electrophysiology (EP) Products, Abbott Canada
His primary responsibility to help grow the Canadian EP business through strategic planning and execution. This involves (among many things) developing partnerships with various Key Opinion Leaders (KOLs), implementing internal/external education, information sharing, and sales team support. He has over 10 years of experience in the medical device industry as a clinical support specialist, sales manager, and now a marketing professional. Having been involved in several corporate acquisitions, most recently with Abbott acquisition of St. Jude Medical in early 2017, Phil can provide perspective as an acquiree and acquirer. Phil has a Bachelor of Science in Biology from Western University and recently completed his MBA at Schulich School of Business with a specialization in Health Industry Management.

ABOUT THE CENTRE: Launched in 2004, the Centre for Health Sector Strategy @ Rotman is a strategic area of focused research for the Rotman School. Under the direction of Professor Brian R. Golden and a board of advisors from industry, government and academia, the centre drives a research agenda that produces actionable management knowledge for the health sector and the life sciences.

NEW - Global Executive MBA for Healthcare and the Life Sciences: The pace of change in healthcare and the life sciences sector has been accelerating, creating a demand for professionals who can navigate the strategic, economic, political, and social undercurrents that are changing the face of this global structure. To meet the challenge, the Rotman School of Management is introducing its Global Executive MBA for Healthcare and the Life Sciences. Grounded in world-class thought leadership and practical instruction, this 18-month program will you help develop the expertise you need to drive your career.


416-978- 6119 or 416-978-6122

Cancellation Policy

Cancellations received in writing to 24 hours prior to the event will receive a refund less a $10 administration fee per person. If we do not receive written notice of your cancellation, you will be charged the full amount for this session. Substitutions are always welcome.
© Rotman School of ManagementAASCB